Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367397002> ?p ?o ?g. }
- W4367397002 endingPage "7" @default.
- W4367397002 startingPage "1" @default.
- W4367397002 abstract "Primary Sjögren's syndrome (pSS) is a chronic inflammatory autoimmune disease primarily affecting the exocrine glands, which has a variety of clinical manifestations and unclear pathogenic mechanisms. Adenosine deaminase (ADA) is an enzyme involved in the breakdown of purines, and changes in its activity have been associated with a number of autoimmune diseases. This study aims to investigate the relationship between serum ADA activity and disease activity in patients with pSS. In this study, 196 patients with pSS and 196 healthy controls were enrolled. Serum ADA activity and clinical laboratory parameters were collected and analyzed in both groups. Pearson correlation analysis was used to examine the correlation between ADA activity and clinical laboratory parameters, as well as the correlation between ADA activity and the disease activity score. Compared with healthy controls, the activity of ADA in the serum of pSS patients was significantly increased (P < 0.0001), and the ADA activity was significantly decreased after immunosuppressive treatment (P < 0.0001). Correlation analysis revealed that the activity of ADA was significantly positively correlated with erythrocyte sedimentation rate (ESR) (r = 0.3, P < 0.0001) and serum immunoglobulin G (IgG) levels (r = 0.5, P < 0.0001), and significantly negatively correlated with high-density lipoprotein (HDL) (r = −0.4, P < 0.0001). Furthermore, there was a significant positive correlation between ADA activity and the disease activity score as measured by the Sjögren's Syndrome Disease Activity Index (SSDAI) (r = 0.4, P < 0.0001). This study found that patients with pSS have higher activity of ADA in serum, which is associated with disease activity as measured by SSDAI. These results suggest that ADA activity may be a potential biomarker for evaluating disease activity and treatment efficacy in pSS patients. Additionally, ADA may be a potential target for the treatment of pSS patients." @default.
- W4367397002 created "2023-04-30" @default.
- W4367397002 creator A5013613251 @default.
- W4367397002 creator A5018863416 @default.
- W4367397002 creator A5023683520 @default.
- W4367397002 creator A5037824528 @default.
- W4367397002 creator A5040339136 @default.
- W4367397002 creator A5045195341 @default.
- W4367397002 creator A5084808312 @default.
- W4367397002 date "2023-06-01" @default.
- W4367397002 modified "2023-10-16" @default.
- W4367397002 title "Correlation of serum adenosine deaminase activity with disease activity in patients with primary Sjögren's syndrome" @default.
- W4367397002 cites W1513969749 @default.
- W4367397002 cites W1554232669 @default.
- W4367397002 cites W1969302149 @default.
- W4367397002 cites W1999996997 @default.
- W4367397002 cites W2081687761 @default.
- W4367397002 cites W2159636934 @default.
- W4367397002 cites W2162689559 @default.
- W4367397002 cites W2167208610 @default.
- W4367397002 cites W2521254998 @default.
- W4367397002 cites W2521824087 @default.
- W4367397002 cites W2580259809 @default.
- W4367397002 cites W2791254798 @default.
- W4367397002 cites W2810265958 @default.
- W4367397002 cites W2964045316 @default.
- W4367397002 cites W3099767975 @default.
- W4367397002 cites W3171976197 @default.
- W4367397002 cites W3174848623 @default.
- W4367397002 cites W4210747590 @default.
- W4367397002 cites W4281626228 @default.
- W4367397002 cites W4317781001 @default.
- W4367397002 doi "https://doi.org/10.1016/j.imlet.2023.04.010" @default.
- W4367397002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37127120" @default.
- W4367397002 hasPublicationYear "2023" @default.
- W4367397002 type Work @default.
- W4367397002 citedByCount "0" @default.
- W4367397002 crossrefType "journal-article" @default.
- W4367397002 hasAuthorship W4367397002A5013613251 @default.
- W4367397002 hasAuthorship W4367397002A5018863416 @default.
- W4367397002 hasAuthorship W4367397002A5023683520 @default.
- W4367397002 hasAuthorship W4367397002A5037824528 @default.
- W4367397002 hasAuthorship W4367397002A5040339136 @default.
- W4367397002 hasAuthorship W4367397002A5045195341 @default.
- W4367397002 hasAuthorship W4367397002A5084808312 @default.
- W4367397002 hasConcept C117220453 @default.
- W4367397002 hasConcept C126322002 @default.
- W4367397002 hasConcept C134018914 @default.
- W4367397002 hasConcept C159654299 @default.
- W4367397002 hasConcept C181199279 @default.
- W4367397002 hasConcept C185592680 @default.
- W4367397002 hasConcept C203014093 @default.
- W4367397002 hasConcept C2524010 @default.
- W4367397002 hasConcept C2776991684 @default.
- W4367397002 hasConcept C2778143017 @default.
- W4367397002 hasConcept C2779075594 @default.
- W4367397002 hasConcept C2779134260 @default.
- W4367397002 hasConcept C28212737 @default.
- W4367397002 hasConcept C33923547 @default.
- W4367397002 hasConcept C34628245 @default.
- W4367397002 hasConcept C55493867 @default.
- W4367397002 hasConcept C71924100 @default.
- W4367397002 hasConcept C90924648 @default.
- W4367397002 hasConceptScore W4367397002C117220453 @default.
- W4367397002 hasConceptScore W4367397002C126322002 @default.
- W4367397002 hasConceptScore W4367397002C134018914 @default.
- W4367397002 hasConceptScore W4367397002C159654299 @default.
- W4367397002 hasConceptScore W4367397002C181199279 @default.
- W4367397002 hasConceptScore W4367397002C185592680 @default.
- W4367397002 hasConceptScore W4367397002C203014093 @default.
- W4367397002 hasConceptScore W4367397002C2524010 @default.
- W4367397002 hasConceptScore W4367397002C2776991684 @default.
- W4367397002 hasConceptScore W4367397002C2778143017 @default.
- W4367397002 hasConceptScore W4367397002C2779075594 @default.
- W4367397002 hasConceptScore W4367397002C2779134260 @default.
- W4367397002 hasConceptScore W4367397002C28212737 @default.
- W4367397002 hasConceptScore W4367397002C33923547 @default.
- W4367397002 hasConceptScore W4367397002C34628245 @default.
- W4367397002 hasConceptScore W4367397002C55493867 @default.
- W4367397002 hasConceptScore W4367397002C71924100 @default.
- W4367397002 hasConceptScore W4367397002C90924648 @default.
- W4367397002 hasFunder F4320324852 @default.
- W4367397002 hasFunder F4320330237 @default.
- W4367397002 hasFunder F4320335466 @default.
- W4367397002 hasLocation W43673970021 @default.
- W4367397002 hasLocation W43673970022 @default.
- W4367397002 hasOpenAccess W4367397002 @default.
- W4367397002 hasPrimaryLocation W43673970021 @default.
- W4367397002 hasRelatedWork W1978639835 @default.
- W4367397002 hasRelatedWork W1992423160 @default.
- W4367397002 hasRelatedWork W2017770252 @default.
- W4367397002 hasRelatedWork W2028520233 @default.
- W4367397002 hasRelatedWork W2056270585 @default.
- W4367397002 hasRelatedWork W2058991568 @default.
- W4367397002 hasRelatedWork W2117564488 @default.
- W4367397002 hasRelatedWork W2130981205 @default.
- W4367397002 hasRelatedWork W2284240597 @default.
- W4367397002 hasRelatedWork W2320914227 @default.